Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2372783
Max Phase: Preclinical
Molecular Formula: C44H66N12O11
Molecular Weight: 939.08
Molecule Type: Protein
Associated Items:
ID: ALA2372783
Max Phase: Preclinical
Molecular Formula: C44H66N12O11
Molecular Weight: 939.08
Molecule Type: Protein
Associated Items:
Canonical SMILES: CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O[C@@H](C)C(=O)O)C1CCCC1)C(C)C
Standard InChI: InChI=1S/C44H66N12O11/c1-24(2)35(54-37(59)30(51-34(58)22-47-4)11-7-17-49-44(45)46)39(61)52-31(19-26-13-15-29(57)16-14-26)38(60)55-36(27-9-5-6-10-27)40(62)53-32(20-28-21-48-23-50-28)41(63)56-18-8-12-33(56)43(66)67-25(3)42(64)65/h13-16,21,23-25,27,30-33,35-36,47,57H,5-12,17-20,22H2,1-4H3,(H,48,50)(H,51,58)(H,52,61)(H,53,62)(H,54,59)(H,55,60)(H,64,65)(H4,45,46,49)/t25-,30-,31-,32-,33-,35-,36-/m0/s1
Standard InChI Key: KKIGVMASGUOMPO-DIUSPMSXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 939.08 | Molecular Weight (Monoisotopic): 938.4974 | AlogP: -1.55 | #Rotatable Bonds: 25 |
Polar Surface Area: 354.75 | Molecular Species: ZWITTERION | HBA: 13 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.59 | CX Basic pKa: 10.81 | CX LogP: -3.20 | CX LogD: -4.12 |
Aromatic Rings: 2 | Heavy Atoms: 67 | QED Weighted: 0.02 | Np Likeness Score: 0.14 |
1. Nyéki O, Szalay KS, Kisfaludy L, Kárpáti E, Szporny L, Makara GB, Varga B.. (1987) Synthesis of angiotensin II antagonists with variations in position 5., 30 (10): [PMID:3656348] [10.1021/jm00393a006] |
Source(1):